Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APLD NASDAQ:ARM NASDAQ:CRWV NASDAQ:NBIS NASDAQ:NVDA NASDAQ:RXRX NASDAQ:WRD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLDApplied Digital$35.90+4.8%$21.48$3.31▼$40.20$9.58B6.7737.95 million shs24.20 million shsARMARM$171.50+3.6%$147.59$80.00▼$182.88$174.97B4.15.95 million shs3.65 million shsCRWVCoreWeave$127.06-7.2%$116.83$33.51▼$187.00$66.87BN/A31.33 million shs25.28 million shsNBISNebius Group$109.00-3.9%$94.14$14.09▼$141.10$26.74B3.4518.36 million shs17.74 million shsNVDANVIDIA$182.64-0.3%$179.41$86.62▼$195.62$4.45T2.12181.52 million shs128.13 million shsRXRXRecursion Pharmaceuticals$6.68+14.0%$5.15$3.79▼$12.36$2.54B0.9166.80 million shs89.72 million shsWRDWeRide$10.37+2.7%$10.17$6.03▼$44.00$2.97BN/A8.93 million shs3.70 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLDApplied Digital+4.85%+4.85%+75.29%+227.85%+338.88%ARMARM+3.56%-0.26%+20.01%+9.58%+12.07%CRWVCoreWeave-7.17%-10.28%+1.76%-2.09%+12,705,999,900.00%NBISNebius Group-3.91%-19.53%+9.76%+113.68%+475.50%NVDANVIDIA-0.32%-3.02%+3.38%+9.35%+32.35%RXRXRecursion Pharmaceuticals+13.99%+20.80%+36.05%+2.14%-3.75%WRDWeRide+2.67%-3.62%-10.06%+9.39%+1,036,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPLDApplied Digital$35.90+4.8%$21.48$3.31▼$40.20$9.58B6.7737.95 million shs24.20 million shsARMARM$171.50+3.6%$147.59$80.00▼$182.88$174.97B4.15.95 million shs3.65 million shsCRWVCoreWeave$127.06-7.2%$116.83$33.51▼$187.00$66.87BN/A31.33 million shs25.28 million shsNBISNebius Group$109.00-3.9%$94.14$14.09▼$141.10$26.74B3.4518.36 million shs17.74 million shsNVDANVIDIA$182.64-0.3%$179.41$86.62▼$195.62$4.45T2.12181.52 million shs128.13 million shsRXRXRecursion Pharmaceuticals$6.68+14.0%$5.15$3.79▼$12.36$2.54B0.9166.80 million shs89.72 million shsWRDWeRide$10.37+2.7%$10.17$6.03▼$44.00$2.97BN/A8.93 million shs3.70 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPLDApplied Digital+4.85%+4.85%+75.29%+227.85%+338.88%ARMARM+3.56%-0.26%+20.01%+9.58%+12.07%CRWVCoreWeave-7.17%-10.28%+1.76%-2.09%+12,705,999,900.00%NBISNebius Group-3.91%-19.53%+9.76%+113.68%+475.50%NVDANVIDIA-0.32%-3.02%+3.38%+9.35%+32.35%RXRXRecursion Pharmaceuticals+13.99%+20.80%+36.05%+2.14%-3.75%WRDWeRide+2.67%-3.62%-10.06%+9.39%+1,036,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPLDApplied Digital 2.92Moderate Buy$22.10-38.44% DownsideARMARM 2.70Moderate Buy$167.43-2.37% DownsideCRWVCoreWeave 2.53Moderate Buy$127.640.46% UpsideNBISNebius Group 3.00Buy$91.20-16.33% DownsideNVDANVIDIA 3.02Buy$222.2321.68% UpsideRXRXRecursion Pharmaceuticals 2.17Hold$7.258.53% UpsideWRDWeRide 2.33Hold$13.7532.59% UpsideCurrent Analyst Ratings BreakdownLatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/15/2025NVDANVIDIAUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$320.0010/15/2025NVDANVIDIAHSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetHold ➝ Buy$200.00 ➝ $320.0010/15/2025NVDANVIDIAHsbc Global ResSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy10/14/2025CRWVCoreWeaveWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)10/14/2025NBISNebius GroupWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)10/14/2025NVDANVIDIAAreteSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$235.00 ➝ $244.0010/13/2025NVDANVIDIAMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$205.00 ➝ $225.0010/10/2025APLDApplied DigitalNorthland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$40.0010/10/2025APLDApplied DigitalLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$18.00 ➝ $37.0010/10/2025APLDApplied DigitalHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$20.00 ➝ $40.0010/9/2025NVDANVIDIACantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$240.00 ➝ $300.00(Data available from 10/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPLDApplied Digital$144.19M69.64N/AN/A$2.21 per share16.24ARMARM$4.01B45.22$1.30 per share132.15$6.53 per share26.26CRWVCoreWeaveN/AN/AN/AN/AN/AN/ANBISNebius Group$117.50M218.70N/AN/A$13.80 per share7.90NVDANVIDIA$130.50B34.01$3.05 per share59.92$3.25 per share56.20RXRXRecursion Pharmaceuticals$58.84M49.29N/AN/A$2.61 per share2.56WRDWeRide$49.47M61.74N/AN/A$3.84 per share2.70Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPLDApplied Digital-$231.07M-$1.130.00N/AN/A-111.29%-37.14%-12.01%N/AARMARM$792M$0.66172.51147.8410.8016.96%15.56%11.72%11/5/2025 (Estimated)CRWVCoreWeaveN/AN/A0.00∞N/AN/AN/AN/AN/ANBISNebius Group-$641.40M-$0.570.00N/AN/A99.34%6.14%5.32%10/29/2025 (Estimated)NVDANVIDIA$72.88B$3.5152.0345.891.3252.41%101.74%70.72%11/19/2025 (Estimated)RXRXRecursion Pharmaceuticals-$463.66M-$1.780.00N/AN/A-1,004.91%-76.09%-54.29%11/5/2025 (Estimated)WRDWeRide-$350.09M-$2.790.00N/AN/A-595.64%-49.03%-28.72%N/ALatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/5/2025Q2 2026ARMARM$0.34N/AN/AN/A$1.06 billionN/A11/5/2025Q3 2025RXRXRecursion Pharmaceuticals-$0.35N/AN/AN/A$19.36 millionN/A10/29/2025Q3 2025NBISNebius Group-$0.50N/AN/AN/AN/AN/A10/9/2025Q1 2026APLDApplied Digital-$0.11-$0.03+$0.08-$0.07$52.25 million$38.01 million8/27/2025Q2 2026NVDANVIDIA$1.01$1.05+$0.04$1.08$45.65 billion$46.74 billion8/12/2025Q2 2025CRWVCoreWeave-$0.20-$0.27-$0.07-$0.60N/A$1.21 million8/7/2025Q2 2025NBISNebius Group-$0.41-$0.38+$0.03$2.10$95.60 million$105.10 million8/5/2025Q2 2025RXRXRecursion Pharmaceuticals-$0.35-$0.41-$0.06-$0.41$15.38 million$19.10 million7/31/2025Q2 2025WRDWeRideN/A-$0.18N/A-$0.18N/A$17.75 million7/30/2025Q4 2025APLDApplied Digital-$0.12-$0.12N/A-$0.24$42.86 million$38.01 million7/30/2025Q1 2026ARMARM$0.34$0.35+$0.01$0.12$1.06 billion$1.05 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPLDApplied DigitalN/AN/AN/AN/AN/AARMARMN/AN/AN/AN/AN/ACRWVCoreWeaveN/AN/AN/AN/AN/ANBISNebius GroupN/AN/AN/AN/AN/ANVDANVIDIA$0.040.02%N/A1.14%1 YearsRXRXRecursion PharmaceuticalsN/AN/AN/AN/AN/AWRDWeRideN/AN/AN/AN/AN/ALatest NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/27/2025NVDANVIDIAquarterly$0.010.02%9/11/20259/11/202510/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPLDApplied Digital0.290.650.65ARMARMN/A4.994.99CRWVCoreWeave2.790.520.52NBISNebius Group0.3114.7014.70NVDANVIDIA0.084.213.60RXRXRecursion Pharmaceuticals0.023.583.58WRDWeRide0.0111.0310.55Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPLDApplied Digital65.67%ARMARM7.53%CRWVCoreWeaveN/ANBISNebius Group21.90%NVDANVIDIA65.27%RXRXRecursion Pharmaceuticals89.06%WRDWeRideN/AInsider OwnershipCompanyInsider OwnershipAPLDApplied Digital9.50%ARMARMN/ACRWVCoreWeaveN/ANBISNebius GroupN/ANVDANVIDIA4.17%RXRXRecursion Pharmaceuticals8.43%WRDWeRideN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPLDApplied Digital121279.69 million253.12 millionOptionableARMARM8,3301.06 billionN/ANot OptionableCRWVCoreWeave881488.57 millionN/AN/ANBISNebius Group1,371235.75 millionN/AN/ANVDANVIDIA36,00024.30 billion23.29 billionOptionableRXRXRecursion Pharmaceuticals400434.15 million397.55 millionOptionableWRDWeRide3,093294.52 millionN/AN/ANVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX HeadlinesRecent News About These CompaniesWeRide (WRD): Evaluating Valuation After Recent Share Price DeclineOctober 19 at 7:13 PM | finance.yahoo.comWeRide (NASDAQ:WRD) Stock Price Up 8.6% - Should You Buy?October 15, 2025 | marketbeat.comSelf-driving car companies Pony.ai and WeRide get the OK for Hong Kong listingOctober 15, 2025 | techcrunch.comTChina greenlights autonomous driving firms Pony.ai and WeRide's Hong Kong listingsOctober 15, 2025 | cnbc.comChinese autonomous driving firm WeRide taps banks for Hong Kong listing, sources sayOctober 14, 2025 | reuters.comWeRide (NASDAQ:WRD) Stock Price Down 4% - What's Next?October 10, 2025 | marketbeat.comMirae Asset Global Investments Co. Ltd. Lowers Holdings in WeRide Inc. $WRDOctober 10, 2025 | marketbeat.comWeRide (WRD) Soars 12% on Global ExpansionOctober 9, 2025 | insidermonkey.comWeRide (NASDAQ:WRD) Earns "Sell (D-)" Rating from Weiss RatingsOctober 8, 2025 | marketbeat.comWeRide (NASDAQ:WRD) Trading 6.9% Higher - Here's What HappenedOctober 8, 2025 | marketbeat.comWeRide Target of Unusually High Options Trading (NASDAQ:WRD)October 8, 2025 | marketbeat.comWeRide (NASDAQ:WRD) Trading Down 3.5% - What's Next?October 3, 2025 | marketbeat.comWeRide (NasdaqGM:WRD) Valuation in Focus After Autonomous Launch in Ras Al KhaimahOctober 2, 2025 | finance.yahoo.comWeRide (NASDAQ:WRD) Shares Up 7% - What's Next?October 2, 2025 | marketbeat.comFengHe Fund Management Pte. Ltd. Invests $11.02 Million in WeRide Inc. $WRDOctober 2, 2025 | marketbeat.comWeRide Launches Robotaxi and Robobus Pilots in Ras Al Khaimah, Expanding Into Third UAE EmirateOctober 2, 2025 | globenewswire.comWeRide Aims to Have Up to 1,000 Robotaxis in Middle East in 2026October 1, 2025 | wsj.comWeRide (NASDAQ:WRD) Upgraded at CitigroupOctober 1, 2025 | marketbeat.comWeRide Wins Dubai World Challenge for Self-Driving Transport, Secures Robotaxi Trial PermitOctober 1, 2025 | insidermonkey.comThe World's First! Uber Launches Exclusive Identifier for WeRide's RobotaxiSeptember 30, 2025 | sohu.comSWeRide Aims to Have Up 1,000 Robotaxis in Middle East in 2026September 29, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCarmax: Now is the Time to Load Up On This Used Car StockBy Thomas Hughes | September 26, 2025Top Insider Buys and Sells From September: Buy, Sell, or Hold?By Thomas Hughes | September 29, 2025AMD Could Double From Here—Thanks to Its Blockbuster OpenAI DealBy Thomas Hughes | October 7, 2025Is Super Micro Next in Line for a Big AI Takeover?By Gabriel Osorio-Mazilli | September 23, 2025NVIDIA Breaks Out to New Highs: What Comes Next?By Thomas Hughes | October 2, 2025NVDA, CRWV, ARM, APLD, NBIS, WRD, and RXRX Company DescriptionsApplied Digital NASDAQ:APLD$35.90 +1.66 (+4.85%) As of 10/20/2025 04:00 PM EasternApplied Digital Corporation designs, develops, and operates datacenters in North America. Its datacenters provide digital infrastructure solutions to the high-performance computing industry. The company also provides artificial intelligence cloud services, high performance computing datacenter hosting, and crypto datacenter hosting services. The company was formerly known as Applied Blockchain, Inc. and changed its name to Applied Digital Corporation in November 2022. Applied Digital Corporation is based in Dallas, Texas.ARM NASDAQ:ARM$171.50 +5.89 (+3.56%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$172.10 +0.60 (+0.35%) As of 10/20/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.CoreWeave NASDAQ:CRWV$127.06 -9.81 (-7.17%) As of 10/20/2025 04:00 PM EasternCoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.Nebius Group NASDAQ:NBIS$109.00 -4.44 (-3.91%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$109.88 +0.88 (+0.81%) As of 10/20/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nebius Group N.V., a technology company, builds intelligent products and services powered by machine learning and other technologies to help consumers and businesses navigate the online and offline world. The company's services include Nebius AI, an AI-centric cloud platform that offers infrastructure and computing capability for AI deployment and machine-learning oriented solutions; and Toloka AI that offers generative AI (GenAI) solutions at every stage of the GenAI lifecycle, such as data annotation and generation, model training and fine-tuning, and quality assessment of large language model for accuracy and reliability. It also offers Avride, an autonomous driving solution which targets ride-hailing, logistics, e-commerce, and food/grocery delivery as application domains, as well as focuses on autonomous vehicles and delivery robots; and TripleTen, an EdTech service that prepares specialists for STEM roles, and equipping them with essential technology skills. The company was formerly known as Yandex N.V. and changed its name to Nebius Group N.V. in August 2024. Nebius Group N.V. was founded in 1989 and is based in Schiphol, the Netherlands.NVIDIA NASDAQ:NVDA$182.64 -0.58 (-0.32%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$182.78 +0.14 (+0.08%) As of 10/20/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. The Compute & Networking segment comprises Data Center computing platforms and end-to-end networking platforms, including Quantum for InfiniBand and Spectrum for Ethernet; NVIDIA DRIVE automated-driving platform and automotive development agreements; Jetson robotics and other embedded platforms; NVIDIA AI Enterprise and other software; and DGX Cloud software and services. The company's products are used in gaming, professional visualization, data center, and automotive markets. It sells its products to original equipment manufacturers, original device manufacturers, system integrators and distributors, independent software vendors, cloud service providers, consumer internet companies, add-in board manufacturers, distributors, automotive manufacturers and tier-1 automotive suppliers, and other ecosystem participants. NVIDIA Corporation was incorporated in 1993 and is headquartered in Santa Clara, California.Recursion Pharmaceuticals NASDAQ:RXRX$6.68 +0.82 (+13.99%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$6.83 +0.15 (+2.25%) As of 10/20/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.WeRide NASDAQ:WRD$10.37 +0.27 (+2.67%) Closing price 10/20/2025 04:00 PM EasternExtended Trading$10.42 +0.06 (+0.53%) As of 10/20/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.WeRide, Inc. engages in the development of an autonomous driving technology platform. It offers Robotaxi, Robobus, Robovan, Robosweeper, and advanced driving solutions, providing smart services in online ride-hailing, on-demand transport, urban logistics, and environmental sanitation. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet Waymo’s Global Expansion Strengthens the Case for GOOGL Stock Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Meta vs OpenAI: Is Sora a True Threat to Meta's Dominance? Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall? Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
